GEC Newswire - Dynamic Technology & Media Coverage Across the Region You’ve more than likely heard of Ozempic, the diabetes drug hailed as a...
Vous n'êtes pas connecté
Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass, and combined with a GLP-1 agonist like Ozempic, increased it by 700%. The team discovered that alpha cells could potentially be transformed into beta cells, offering a new source for insulin production.
GEC Newswire - Dynamic Technology & Media Coverage Across the Region You’ve more than likely heard of Ozempic, the diabetes drug hailed as a...
GEC Newswire - Dynamic Technology & Media Coverage Across the Region You’ve more than likely heard of Ozempic, the diabetes drug hailed as a...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin-a critical hormone that...
One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK (natural killer) cells....
Amy Schumer enjoyed the 'night of a lifetime' with two gal pals in Las Vegas, NV on Saturday. The 44-year-old comedian showcased her substantial...
Amy Schumer enjoyed the 'night of a lifetime' with two gal pals in Las Vegas, NV on Saturday. The 44-year-old comedian showcased her substantial...
Dorothy Draper’s fearless vision transformed interiors with bold color, drama, and a new kind of elegance. ......
THURSDAY, Oct. 16, 2025 — Weight-loss drugs like Ozempic and Zepbound appear to reduce alcohol cravings, but doctors have been at a loss to explain...
WHILE semaglutide and other GLP-1 receptor agonist medications may offer rapid results for obesity management, their benefits appear less enduring...
When cancer cells are physically squeezed, they mount an instant,...